UK markets open in 7 hours 32 minutes
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.24 +0.25 (+0.32%) GOLD FUTURES
2,316.10 -6.20 (-0.27%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
48,740.04 -1,135.06 (-2.28%)
JCR Pharmaceuticals Co., Ltd. (4552.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
At close: 03:15PM JST
| Previous close | 806.00 |
| Open | 806.00 |
| Bid | 0.00 x 0 |
| Ask | 800.00 x 0 |
| Day's range | 800.00 - 814.00 |
| 52-week range | 773.00 - 1,567.00 |
| Volume | |
| Avg. volume | 685,594 |
| Market cap | 99.841B |
| Beta (5Y monthly) | 0.01 |
| PE ratio (TTM) | 18.69 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 20.00 (2.48%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | N/A |
- Business Wire
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
HYOGO, Japan, March 19, 2024--JCR Pharmaceuticals announces achievement of milestone using J-Brain Cargo® for neurodegenerative disease in research collaboration with Alexion.
- Business Wire
JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
HYOGO, Japan, February 29, 2024--JCR Pharmaceuticals celebrates Rare Disease Day 2024 and highlights its commitment to the rare disease community.
- Business Wire
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
HYOGO, Japan, February 14, 2024--JCR announced the presentation of several datasets demonstrating the potential benefits of its investigational LSD therapies at the WORLDSymposium™.
© 2024 Yahoo. All rights reserved.